Novavax

Centre Must Take Responsibility for Vaccine Shortages and Act Now

Covishield Blood Clot Risk Minuscule but Govt Not Transparent: Gagandeep Kang

India’s Other COVID-19 Vaccines Held Up By Shortage of Raw Materials, Data

Are the New Variants Driving India’s Second COVID-19 Wave?

Mutations: Does SARS-CoV-2 Have a Fixed Number of Moves in Its Arsenal?

Serum Institute Delays Expected Launch of Novavax Vaccine in India

Pfizer Wants To Make Vaccine In India If Faster Clearance, Export Freedom Assured